- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 30, 2025 | 3.12M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 3.12M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 3.12M sh |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 3.03M sh |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 3.03M sh |
| Capex | Q2 2025 · Dec 31, 2024 | $163.92K |
| Capex | Q2 2025 · Dec 31, 2023 | $495.3K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | −$2.39M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$3.94M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $1.52M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $4.14M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $21.05M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $23.56M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $25.65M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $34.49M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $37.29M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $39.77M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $14.82M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $14.13M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $15.58M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $15.33M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $15.09M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $18.82M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $36.63M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $40.98M |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.81 |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$1.50 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$0.94 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$1.78 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$0.81 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$1.50 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$0.94 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$1.78 |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $1.27M |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $2.53M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $1.5M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $3.35M |
| Net Income | Q2 2025 · Dec 31, 2024 | −$2.54M |
| Net Income | Q2 2025 · Dec 31, 2024 | −$4.67M |
| Net Income | Q2 2025 · Sep 30, 2024 | −$2.13M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$2.87M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$5.41M |
| Net Income | Q2 2025 · Sep 30, 2023 | −$2.54M |
| Operating Income | Q2 2025 · Dec 31, 2024 | −$2.54M |
| Operating Income | Q2 2025 · Dec 31, 2024 | −$4.68M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$2.94M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$5.57M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $3.12M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $5.36M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $5.05M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2023 | $8.06M |
| Revenue | Q2 2025 · Dec 31, 2024 | $4.63M |
| Revenue | Q2 2025 · Dec 31, 2024 | $7.86M |
| Revenue | Q2 2025 · Dec 31, 2023 | $7.91M |
| Revenue | Q2 2025 · Dec 31, 2023 | $12.86M |